Permanent muscle weakness in McArdle disease

Muscle and Nerve

Volumn 40, Issue 3, 2009, Pages 350-357

  Nadaj Pakleza, Aleksandra A ^a   Vincitorio, Carlo M ^a   Laforêt, Pascal ^a   Eymard, Bruno ^a   Dion, Elisabeth ^b   Teijeira, Susana ^c   Vietez, Irene ^c   Jeanpierre, Marc ^d   Navarro, Carmen ^c   Stojkovic, Tanya ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL LOUIS MOURIER   (France)

^c HOSPITAL DO MEIXOEIRO   (Spain)

^d Cochin Hospital ^*  (France)

Author keywords

CT scan; Genotype; Glycogenosis, McArdle; Muscle weakness

Indexed keywords

ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FEMALE; GLYCOGEN STORAGE DISEASE TYPE 5; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOGLOBINURIA; PELVIC GIRDLE; PRIORITY JOURNAL;

AGED; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; ELECTROMYOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLYCOGEN PHOSPHORYLASE, MUSCLE FORM; GLYCOGEN STORAGE DISEASE TYPE V; HUMANS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; MUTATION; MYOGLOBINURIA; TOMOGRAPHY SCANNERS, X-RAY COMPUTED;

EID: 69749125320     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21351     Document Type: Article

References (22)

1. Aquaron R, Berge-Lefranc JL, Pellissier JF, Montfort MF, Mayan M, Figarella-Branger D, et al. Molecular characterization of myophosphorylase deficiency (McArdle disease) in 34 patients from southern France: identification of 10 new mutations. Absence of genotype-phenotype correlation. Neuromuscul Disord 2007;17:235-241.
2. Brooke MH, Griggs RC, Mendell JR, Fenichel GM, Shumate JB, Pellegrino RJ. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve 1981;4:186-197.
3. Clemens PR, Yamamoto M, Engel AG. Adult phosphorylase b kinase deficiency. Ann Neurol 1990;28:529-538.
4. De Kerviler E, Leroy-Willig A, Duboc D, Eymard B, Syrota A. MR quantification of muscle fatty replacement in McArdle disease. Magn Reson Imaging 1996;14:1137-1141. (Pubitemid 27124210)
5. DiMauro S, Hartwig GB, Hays A, Eastwood AB, Franco R, Olarte M, et al. Debrancher deficiency: neuromuscular disorder in 5 adults. Ann Neurol 1979;5:422-436. (Pubitemid 9150134)
6. DiMauro S, Hayes AP, Tsujino S. Nonlysosomal glycogenoses. In: Engel AG Franzini-Armstrong C, editors. Myology. New York: McGraw-Hill; 2004. p. 1535-1558.
7. Engel WK, Eyerman EL, Williams HE. Late-onset type of skeletal-muscle phosphorylase deficiency. A new familial variety with completely and partially affected subjects. N Engl J Med 1963;268:135-137.
8. Felice KJ, Schneebaum AB, Jones HR Jr. McArdle disease with late-onset symptoms: case report and review of the literature. J Neurol Neurosurg Psychiatry 1992;55:407-408.
9. Fischer D, Herasse M, Bitoun M, Barragán-Campos HM, Chiras J, Laforêt P, et al. Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy. Brain 2006;129:1463-1469. (Pubitemid 43999379)
10. Fischer D, Herasse M, Ferreiro A, Barragán-Campos HM, Chiras J, Viollet L, et al. Muscle imaging in dominant core myopathies linked or unlinked to the ryanodine receptor 1 gene. Neurology 2006;67:2217-2220. (Pubitemid 46035480)
11. Hagemans ML, Winkel LP, Van Doorn PA, Hop WJ, Loonen MC, Reuser AJ, et al. Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients. Brain 2005;128:671-677.
12. Hewlett RH, Gardner-Thorpe C. McArdle disease - what limit to the age of onset? S Afr Med J 1978;53:60-63.
13. Kishnani PS, Hwu WL, Mandel H, Nicolino M, Yong F, Corzo D, et al. A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr 2006;148:671-676. (Pubitemid 43776899)
14. Kubisch C, Wicklein EM, Jentsch TJ. Molecular diagnosis of McArdle disease: revised genomic structure of the myophosphorylase gene and identification of a novel mutation. Hum Mutat 1998;12:27-32. (Pubitemid 28262221)
15. Lamminen AE. Magnetic resonance imaging of primary skeletal muscle diseases: patterns of distribution and severity of involvement. Br J Radiol 1990;63:946-950.
16. Laforêt P, Nicolino M, Eymard PB, Puech JP, Caillaud C, Poenaru L, et al. Juvenile and adult-onset acid maltase deficiency in France: genotype-phenotype correlation. Neurology 2000;55:1122-1128. (Pubitemid 30802990)
17. Mastaglia FL, McCollum JP, Larson PF, Hudgson P. Steroid myopathy complicating McArdle disease. J Neurol Neurosurg Psychiatry 1970;33:111-120.
18. Martin MA, Rubio JC, Buchbinder J, Fernández-Hojas R, del Hoyo P, Teijeira S, et al. Molecular heterogeneity of myophosphorylase deficiency (McArdle disease): a genotype-phenotype correlation study. Ann Neurol 2001;50:574-581. (Pubitemid 33021914)
19. Papadimitriou A, Manta P, Divari R, Karabetsos A, Papadimitriou E, Bresolin N. McArdle disease: two clinical expressions in the same pedigree. J Neurol 1990;237:267-270. (Pubitemid 20213315)
20. Pourmand R, Sanders DB, Corwin HM. Late-onset McArdle disease with unusual electromyographic findings. Arch Neurol 1983;40:374-377.
21. Wolfe GI, Baker NS, Haller RG, Burns DK, Barohn RJ. McArdle disease presenting with asymmetric, late-onset arm weakness. Muscle Nerve 2000;23:641-645.
22. Zhang Y, Forner J, Fournet S, Jeanpierre M. Improved characterization of FSHD mutations. Ann Genet 2001;44:105-110.